Genentech released the quarterly fatalities report for Emicizumab (Hemlibra) and there are now 34 reported deaths. This makes it the most reported deaths for...

The Cure 4 The Kids Foundation based in Las Vegas, Nevada lost its funding due to misappropriating federal funds. Annette Logan-Parker (pictured left), who r...

Well, like clockwork, Genentech has released the quarterly fatalities report for Hemlibra.(Emicizumab) A few weeks ago, we published a post about the New En...

Just as gene therapy finally seems to be living up to its promise, a study has revived a lingering worry about the viral vessel that many efforts rely on to ...

Well, we are now in 2020. Last year was kind of rocky for the bleeding disorder community. There was a lot of not-so-good news that we informed the community...

On November 7, 2019, the New England Journal of Medicine published a letter to the Editor from Louis M. Aledort, M.D. from the Icahn School of Medicine at Mo...

Sanofi SA’s Genzyme unit cannot block a former employee from joining BioMarin Pharmaceutical Inc, where he would help launch a gene therapy treatment for hem...

Well, Genentech just released their quarterly fatalities report on Emicizumab (Hemlibra) and we are now up to 17. This is 4 more than last quarter. Again, th...

Tremeau Pharmaceuticals, a private Massachusetts company, is developing a generic version of Vioxx as a treatment for severe joint pain in people with hemoph...

Ah, there is no shortage of news these days with these pharma companies. It’s a great time to have a bleeding disorder news website. CSL Behring has advised ...

HemoAware's President and CEO, Jesse John Francis Clark was interviewed by MDedge for an article on Genentech's translucent particle statement. We have poste...

Cambridge, Massachusetts-based bluebird bio and Bagsvaerd, Denmark-based Novo Nordisk announced they have agreed to collaborate to develop next-generation ge...

Today, Genentech released a statement (see below) regarding particulate matter found in Emicizumab. (HEMLIBRA) They noticed the matter back in March. It's now...

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into an expanded agreement with Sanofi to exercise early opt-in for the development and com...

On August 1, 2019, Medvantx shipped ancillary supplies, including syringes, transfer needles, injection needles, alcohol prep pads, gauze sponges, and adhesi...

Bayer annouced a recall on two (2) lots of Kogenate FS 2000 IU vials. What these lots were supposed to contain were vials labled as Kogenate FS but were actu...

BioMarin are dropping the 4e13 dose for thier Hemophilia A gene therapy and are going for 6e13 for all. They are trying to aim for a 1 year data on 130 patie...

Genentech has released an updated fatalities report. They have reported 13 fatalities to date. Again, they give no information regarding the circumstances su...

BioMarin Pharmaceutical said that it plans to submit marketing applications to both the U.S. Food and Drug Administration and the European Medicines Agency i...

The global Hemophilia Treatment Market is anticipated USD 14 billion by 2025; according to a new research study published by Global Market Insights, Inc. inc...